Skip to main content

MoneyWorks4Me

Aurobindo Pharma board to consider Un-Audited Financial Results

22 Jan 2014 Evaluate

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2014, to consider the Un-Audited Financial Results of the Company for the quarter ended December 31, 2013 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..